Advanced Container (ACTX) 10-Q 24 Jun 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Jun. 24, 2020
Document And Entity Information
Entity Registrant Name	Medtainer, Inc.
Entity Central Index Key	0001096950
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Shell Company	false
Small Business	true
Emerging Growth Company	true
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	No
Entity Filer Category	Non-accelerated Filer
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		77,085,272
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020

Balance Sheets

Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash	$ 31,377	$ 17,982
Accounts receivable	129,405	108,836
Inventories	80,125	85,215
Prepaid expenses		8,967
TOTAL CURRENT ASSETS	240,907	221,000
Property and equipment, net of accumulated depreciation of $124,053 and $118,459, respectively	29,690	35,280
Intangible assets, net of accumulated amortization of $146,524 and $126,322	1,385,476	1,405,678
Goodwill	1,020,314	1,020,314
Security deposits	7,699	7,699
TOTAL ASSETS	2,684,086	2,689,971
CURRENT LIABILITIES:
Accounts payable and accrued expenses	367,724	234,635
Accrued interest payable	142,035	142,464
Payroll liabilities payable	195,150	162,409
Customer deposits payable	60,745	97,310
Convertible notes payable	81,172	81,172
Notes payable	373,959	373,959
Loans payables - stockholders	676,796	627,162
TOTAL CURRENT LIABILITIES	1,897,581	1,719,111
SHAREHOLDERS' EQUITY DEFICIENCY
Preferred stock, without par value, issuable in series, 10,000,000 shares authorized: none issued
Common stock, par value $0.00001 per share, 100,000,000 shares authorized: 56,700,979 shares issued and outstanding shares at March 31, 2020, and December 31, 2019	567	567
Additional paid In capital	6,054,693	5,905,656
Accumulated deficit	(5,268,755)	(4,935,363)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	786,505	970,860
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 2,684,086	$ 2,689,971

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Office Equipment Net Depreciation	$ 124,053	$ 118,459
Intangible Assets, net of accumulated amortization	$ 146,524	$ 126,322
Preferred Stock Par Value	$ 0	$ 0
Preferred Stock Shares Authorized	10,000,000	10,000,000
Preferred Stock Shares Issued	0	0
Preferred Stock Shares Outstanding	0	0
Common Stock Par Value	$ 0.00001	$ 0.00001
Common Stock Shares Authorized	100,000,000	100,000,000
Common Stock Shares Issued	56,700,979	56,700,979
Common Stock Shares Outstanding	56,700,979	56,700,979

Statements of Operations

Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Sales	$ 556,129	$ 604,437
Cost of sales	275,989	263,159
Gross profit	280,140	341,278
Operating expenses:
Advertising and marketing	13,349	15,673
Depreciation and amortization	24,674	27,824
Professional fees	64,890	3,829
Share Based Compernsation	149,037	420,642
Payroll expenses	285,298	293,357
General and administrative expense	66,531	41,627
Total operating expenses	603,779	802,952
Loss from operations	(323,639)	(461,674)
Non-operating income (expense)
Interest expense	(9,753)	(9,884)
Total non-operarting expense	(9,753)	(9,884)
Loss before income taxes	(333,392)	(471,558)
Income tax provision
Net loss	$ (333,392)	$ (471,558)
Basic and diluted loss per common share	$ (0.01)	$ (0.01)
Basic weighted average common shares outstanding	56,700,979	56,250,784
Diluted weighted average common shares outstanding	57,086,933	56,999,130

Statements of Cash Flows

Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
OPERATING ACTIVITIES:
Net loss	$ (333,392)	$ (471,558)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	5,590	7,622
Share-based Compensation	149,037	420,642
Amortization expense	20,202	20,202
Changes in operating assets and liabilities
Accounts receivable	(20,569)	(54,743)
Inventories	5,090	15,448
Prepaid expenses	8,967	(3,074)
Accounts payable and accrued expenses	133,089	58,859
Accrued interest payable	(429)	9,503
Payroll liabilities payable	32,741	17,395
Customer deposits payable	(36,565)	23,687
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	(36,239)	43,983
INVESTING ACTIVITIES:
Acquisition of property and equipment		(1,165)
NET CASH USED IN NVESTING ACTIVITIES		(1,165)
FINANCING ACTIVITIES:
Principal payments on capital lease obligations		(5,619)
Proceeds from stockholder loan	60,238	124,483
Repayment of stockholder loan	(10,604)	(88,483)
NET CASH PROVIDED BY FINANCING ACTIVITIES	49,634	30,381
INCREASE IN CASH	13,395	73,199
CASH - BEGINNING OF YEAR	17,982	17,374
CASH - END OF YEAR	$ 31,377	$ 90,573

Shareholders Equity

Shareholders Equity - USD ($)	Common Stock	Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Shares at Dec. 31, 2018	55,499,106
Beginning Balance, Value at Dec. 31, 2018	$ 555	$ 5,034,636	$ (3,526,913)	$ 1,508,278
Common stock issued in reverse split	1,873
Share Based Compensation, Shares	900,000
Share Based Compensation, Amount	$ 9	420,633		420,642
Net loss			(471,558)	(471,558)
Ending Balance, Shares at Mar. 31, 2019	56,400,979
Ending Balance, Value at Mar. 31, 2019	$ 564	5,455,269	(3,998,471)	(1,457,362)
Beginning Balance, Shares at Dec. 31, 2019	56,700,979
Beginning Balance, Value at Dec. 31, 2019	$ 567	5,905,656	(4,935,363)	970,860
Share Based Compensation, Amount			149,037	149,037
Net loss			(333,392)	(333,392)
Ending Balance, Shares at Mar. 31, 2020	56,700,979
Ending Balance, Value at Mar. 31, 2020	$ 567	$ 6,054,693	$ (5,268,755)	$ 786,505

Business

Business	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business	Note 1 – Business Medtainer, Inc. (the “Company”) is in the business of designing, manufacturing, branding and selling proprietary plastic medical grade containers that can store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs, the business of private labeling and branding for purchasers of containers and other products, and the sale of other products. Prior to January 1, 2019, it conducted these businesses through wholly owned subsidiaries; from and after that date, it has conducted them itself.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Accounting Principles The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the quarter ended March 31, 2020, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on May 28, 2020. Principles of Consolidation The unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Certain of the Company’s estimates could be affected by external conditions, including those unique to its industry, and general economic conditions. It is possible that these external conditions could have an effect on the Company’s estimates that could cause actual results to differ from its estimates. The Company re-evaluates all its accounting estimates at least quarterly based on these conditions and record adjustments when necessary. Significant estimates relied upon in preparing these unaudited consolidated financial statements include revenue recognition, accounts receivable reserves, inventory and related reserves, valuations and purchase price allocations related to business combinations, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to intangible assets and goodwill, amortization periods, accrued expenses, share-based compensation, and recoverability of the Company’s net deferred tax assets and any related valuation allowance. Cash The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents. Accounts Receivable Included in “Accounts receivable” on the consolidated balance sheets are amounts primarily related to customers. The Company estimates losses on receivables based on known troubled accounts and historical experience of losses incurred. Receivables are considered impaired and written off when it is probable that all contractual payments due will not be collected in accordance with the terms of the related agreement. Based on experience and the judgment of management, the allowance for doubtful accounts was $0 as of March 31, 2020, and December 31, 2019. Inventories Inventories, which consist of products held for resale, are stated at the lower of cost, determined using the first-in first-out and net realizable value methods. Net realizable value is the estimated selling price, in the ordinary course of business, less estimated costs to complete and dispose of the product. If the Company identifies excess, obsolete or unsalable items, its inventories are written down to their realizable value in the period in which the impairment is first identified. Shipping and handling costs incurred for inventory purchases and product shipments are recorded in cost of sales in the Company’s statements of operations. Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets. For furniture and fixtures the useful life is 5 years, Leasehold Improvements are depreciated over the 2-year lease term. Expenditures for additions and improvements are capitalized; repairs and maintenance are expensed as incurred. Goodwill and Intangible Assets Goodwill and intangible assets that have indefinite useful lives are not amortized but are evaluated for impairment annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The Company records intangible assets at fair value, estimated using a discounted cash flow approach. The Company amortizes its intangible assets that have finite lives using either the straight-line method or based on estimated future cash flows to approximate the pattern in which the economic benefit of the assets will be utilized. Amortization is recorded over the estimated useful lives ranging from 14 to 20 years. The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that would indicate impairment and trigger a more frequent impairment assessment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, or an adverse action or assessment by a regulator. If the carrying value of an asset exceeds its undiscounted cash flows, the Company will write-down the carrying value of the intangible assets to its fair value in the period identified. The Company generally calculates fair value as the present value of estimated future cash flows to be generated by the asset using a risk-adjusted discount rate. If the estimate of an intangible asset’s remaining useful life is changed, the Company will amortize the remaining carrying value of the intangible asset prospectively over the revised remaining useful life. Consistent with the prior year, the Company conducted its annual impairment test of goodwill during the fourth quarter of the year ended December 31, 2019. The Company operates as a single operating segment with one reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The estimate of fair value requires significant judgment. Any loss resulting from an impairment test would be reflected in operating income in the Company’s consolidated statements of income. The annual impairment testing process is subjective and requires judgment at many points throughout the analysis. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges for these assets not previously recorded. In January 2017, FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment There was no impairment of intangible assets, long-lived assets or goodwill during the quarter ended March 31, 2020. Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt- and equity-linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities. Revenue Recognition In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 20 l4-09, Revenue from Contracts with Customers (Topic 606) Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations; Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing; Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients; Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. The new revenue standards became effective for the Company on January 1, 2018 and were adopted using the modified retrospective method. The adoption of the new revenue standards did not change the Company’s revenue recognition as the majority of its revenues continue to be recognized when the customer takes control of its product. As the Company did not identify any accounting changes that impacted the amount of reported revenues with respect to its product revenues, no adjustment to retained earnings was required upon adoption. Under the new revenue standards, the Company recognizes revenues when its customer obtains control of promised goods or services, or when they are shipped to that customer, in an amount that reflects the consideration which it expects to receive in exchange for them. The Company recognizes revenues following the five-step model prescribed under ASU No. 2014-09: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) the Company satisfies its performance obligation. Revenues from product sales are recognized when the customer obtains control of the Company’s product, which occurs at a point in time, typically upon shipment or delivery to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have recognized is one year or less or the amount is immaterial. The following table summarizes revenue from contracts with customers for the quarter ended March 31, 2020, and March 31, 2019: Quarter Ended March 31, 2020 2019 Products $ 542,875 $ 582,404 Services 13,254 22,033 Totals $ 556,129 $ 604,437 Share-Based Payments In June 2018, FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, Equity—Equity-Based Payments to Non-Employees. Fair Value Measurements The Company has adopted the provisions of ASC Topic 820, Fair Value Measurements and Disclosures, The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of the Company’s short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk. ASC Topic 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC Topic 820 describes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities Level 2 – Quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 – Inputs that are unobservable (for example cash flow modeling inputs based on assumptions) Advertising Advertising and marketing expenses are charged to operations as incurred. Income Taxes The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, Income Taxes. ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts. Also, the Company has not experienced losses on accounts receivable and management believes that the Company is not exposed to significant risks with respect to them. Accounting for Leases In February 2016, FASB issued ASU 2016-02, Leases (Topic 842),

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 – Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. At March 31, 2020, the Company had a working capital deficit of $1,656,674. In addition, the Company has generated operating losses since inception and has notes payable that are currently in default. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the successful execution of its operating plan which includes increasing sales of existing products while introducing additional products and services, controlling operation expenses, negotiating extensions of existing loans and raising either debt or equity financing. There is no assurance that the Company will be able to increase sales or to obtain or extend financing on terms acceptable to us or at all or successfully execute any of the other measures set forth in the previous sentence.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2020
Intangible Assets
Intangible Assets	Note 4 – Intangible Assets Intangible assets that are subject to amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable. Assets not subject to amortization are tested for impairment at least annually. The Company has intangible assets subject to amortization as described in the next paragraph. These costs were included in intangible assets on the balance sheet and amortized as indicated in the next paragraph. On June 8, 2018, the Company acquired certain patents and patent applications, a trademark and an internet domain related to “Medtainer®” pursuant to an Asset Purchase Agreement, dated as of April 16, 2018, and amended on June 8, 2018, by and between the Company and an unrelated party, in consideration of the issuance of 2,631,252 shares of common stock. These assets and the associated goodwill have been apportioned as follows, based upon a report that the Company obtained from an independent valuation firm: Balances at March 31, 2020: Weighted Average Gross Carrying Accumulated Description Estimated Useful Life Value Amortization Net Amount Certain U.S. patents 15 years $ 435,000 $ (51,701 ) $ 383,299 Certain U.S. patents 15 years 435,000 (49,754 ) 385,246 Certain Canadian Patents 20 years 260,000 (23,457 ) 236,543 Certain European Patents 14 years 30,000 (3,783 ) 26,217 Molds 15 years 150,000 (17,829 ) 132,171 Trademark Indefinite life 220,000 — 220,000 Domain name Indefinite life 2,000 — 2,000 Intangible Totals $ 1,532,000 $ (146,524 ) $ 1,385,476 Goodwill $ 1,020,314 $ — $ 1,020,314 Balances at December 31, 2019: Weighted Average Gross Carrying Accumulated Description Estimated Useful Life Value Amortization Net Amount Certain U.S. patents 15 years $ 435,000 $ (44,571 ) $ 390,429 Certain U.S. patents 15 years 435,000 (42,895 ) 392,105 Certain Canadian Patents 20 years 260,000 (20,224 ) 239,776 Certain European Patents 14 years 30,000 (3,262 ) 26,738 Molds 15 years 150,000 (15,370 134,630 Trademark Indefinite life 220,000 — 220,000 Domain name Indefinite life 2,000 — 2,000 Intangible Totals $ 1,532,000 $ (126,322 ) $ 1,405,678 Goodwill $ 1,020,314 $ — $ 1,020,314

Convertible Notes Payable and P

Convertible Notes Payable and Promissory Notes Payable	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Convertible Notes Payable and Promissory Notes Payable	Note 5 – Convertible Notes Payable and Promissory Notes Payable As of March 31, 2020, and December 31, 2019, the Company had the following convertible notes and promissory notes outstanding: March 31, 2020 December 31, 2019 Principal Accrued Principal Accrued Convertible Notes Payable July 2014 $75,000 note, convertible into common stock at $5.00 per share, 10% interest, currently in default (a) $ 66,172 $ 25,366 $ 66,172 $ 23,712 July 2014 $15,000 note, convertible into common stock at $5.00 per share, 10% interest, currently in default (a) 15,000 9,750 15,000 9,125 $ 81,172 $ 35,116 $ 81,172 $ 32,837 Notes Payable November 2014 $300,000 note, due February 2019, 10% interest, currently in default (b) $ 298,959 $ 31,919 $ 298,959 $ 34,627 August 2015 $75,000 note, with one-time interest charge of $75,000, currently in default (c) 75,000 75,000 75,000 75,000 373,959 106,919 373,959 109,627 Total $ 455,131 $ 142,035 $ 455,131 $ 142,464 a. The Company entered into promissory note conversion agreements in the aggregate amount of $90,000. Payments of $8,828 have been made on these notes as of March 31, 2019. These notes are convertible into shares of the Company’s common stock at a conversion price of $5.00 per share. The loans under these agreements are non-interest-bearing and have no stated maturity date; however, the Company is accruing interest at a 10% nominal annual rate. b. On November 3, 2014, the Company made a promissory note in the principal amount of $300,000 in favor of an unrelated person (the “Old Note”). On February 22, 2018, the Company repaid $100,000 on the principal of the Old Note and made a new promissory note, dated February 22, 2018, in the principal amount of $298,959 in favor of said party (the “New Note”) in satisfaction of the Old Note, which principal amount comprised the unpaid principal amount of $200,000 due on the Old Note after the repayment, and $98,959 of accrued interest on the Old Note. At March 31, 2019, accrued interest on this note was $32,387. The outstanding balance of this note was $298,959 at March 31, 2020, and December 31, 2019. The New Note was due on February 22, 2019. This note is in default and the Company is negotiating an extension. The Company made interest payments in the amount of $20,182 and $10,182 to the noteholder during the 12 months ended December 31, 2019, and the quarter ended March 31, 2020, respectively. c. On August 15, 2015, the Company made a promissory note in the amount of $150,000 in favor of an unrelated party. The note bears interest at 0.48% per annum, provided that the note is paid on or before maturity date, or 2 percentage points over the Wall Street Journal Prime Rate, if it is not repaid on or before the maturity date. This note matured on August 11, 2016. Upon an event of default, as defined in the note, interest shall be compounded daily. The Company is currently negotiating an extension of the maturity date for the balance. During the year ended December 31, 2017, the holder of this note agreed to exchange $75,000 of principal and $663 of interest accrued on this note for 500,000 shares of common stock. This exchange was accounted for as an extinguishment of debt resulting in a loss of $683,337. In connection with this exchange, the Company agreed to pay the holder a fee of $75,000 in consideration of his waiving the default under the promissory note, as additional consideration for his agreeing to the exchange and as compensation for his foregoing the interest that would have accrued on the promissory note at the default rate but for the waiver. At March 31, 2020, and December 31, 2019, the note had a balance of $75,000 in addition to the $75,000 fee included in accrued interest.

Stockholders Equity

Stockholders Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Stockholders Equity	Note 6 – Stockholders’ Equity On March 22, 2019, the Company implemented a reverse split of its common stock on the basis of one new share of common stock for each 100 shares of common stock then outstanding. Also, on that date, the Company reduced the number of shares of its authorized common stock from 6,000,000,000 to 100,000,000. All references to common shares have been adjusted for the effects of the reverse split. The number of authorized shares of preferred stock remained 10,000,000.

Share Based Compensation

Share Based Compensation	3 Months Ended
	Mar. 31, 2020
Compensation Related Costs [Abstract]
Share Based Compensation	Note 7 – Share-Based Compensation The Company’s 2018 Incentive Award Plan (the “2018 Plan”) became effective on December 1, 2018, under which the Company may issue up to 2,000,000 shares of common stock, which the Company reserved, as incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, and other forms of compensation to employees, directors and consultants. In addition, the 2018 Plan provides for the grant of performance cash awards to employees, directors and consultants. All these shares were reserved on that date. On December 1, 2018, 1,350,000 shares of common stock were awarded to employees in the form of restricted shares and 335,000 shares of common stock were awarded to consultants as compensation. The fair value of these shares on the grant date was $0.01 per share. As of December 31, 2018, 185,000 shares awarded to consultants were vested and none of the shares awarded to employees were vested. During the quarter ended March 31, 2019, all of the 335,000 shares awarded to consultants were vested and 750,000 of the shares awarded to employees were vested. The Company made no awards in any other form during the quarters ended March 31, 2020, and March 31, 2019. The Company expensed $149,037 and $420,642 for share-based compensation in the quarters ended March 31, 2020, and March 31, 2019, for its employees and nonemployees in the accompanying consolidated statements of operations. The following table summarizes vesting for financial reporting purposes under GAAP of the Common Stock shares issued under the 2018 Plan: Shares of Common Stock Vesting Dates Employees Consultants December 31, 2018 — 185,000 January 1, 2019 750,000 — March 31, 2019 — 150,000 June 30, 2019 300,000 — Total vested at March 31, 2020 1,050,000 335,000

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 8 – Income Taxes As of December 31, 2019, the Company had approximately $3,248,000 of net operating loss carryforwards (“NOLs”) that are available to reduce future taxable income and that begin to expire in 2035. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against all the deferred tax assets for every period because it is more likely than not that all the deferred tax assets will not be realized. On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “2017 Tax Act”) was signed into law, making significant changes to the Internal Revenue Code. Changes include a federal corporate tax rate decrease from 35% to 21% for tax years beginning after December 31, 2017, the transition of U.S. international taxation from a worldwide tax system to a territorial system and a one-time transition tax on the mandatory deemed repatriation of foreign earnings. The Company has estimated its provision for income taxes in accordance with the 2017 Tax Act and the guidance available and has kept the full valuation allowance. As a result, the Company recorded no income tax expense during the quarter ended March 31, 2020.

Capital Leases

Capital Leases	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Capital Leases	Note 9 – Capital Leases During each of the years ended at December 31, 2017, and December 31, 2016, the Company entered a capitalized equipment lease. Each of these leases was payable in 24 monthly installments of $2,000, including interest at the rate of 19.87% per annum. The lessor under these leases was a related party. The Company made its final payments for these leases during June 2018 and May 2019, respectively.

Related-Party Transactions

Related-Party Transactions	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Related-Party Transactions	Note 10 – Related-Party Transactions Loans The Company has received loans from its officers and directors from time to time since 2014. During the quarter ended March 31, 2020, the Company received loans of $60,239 from its officers and directors. During the quarter ended March 31, 2020, the Company repaid $10,603 of the loans. The balances of these loans at March 31, 2020, and December 31, 2019, was $676,796 and $627,162, respectively. All of these loans are non-interest-bearing and have no fixed maturity date. The Company expects to repay of these loans when cash flows become available. Contracts The Company makes capital lease payments for equipment, building lease payments, and products for resale from an entity owned by a related party, who is also one of its executive officers. Payments made to the related party for the quarters ended March 31, 2020, and March 31, 2019, are as follows: Quarter Ended March 31, 2020 2019 Capital lease payments $ — $ 6,000 Building lease payments 21,521 25,921 Purchase of products for resale 26,942 30,221 Total paid to related party $ 48,463 $ 62,142

Concentrations

Concentrations	3 Months Ended
	Mar. 31, 2020
Risks and Uncertainties [Abstract]
Concentrations	Note 11 – Concentrations For the quarter ended March 31, 2020, and March 31, 2019, one of the Company’s customers accounted for approximately 6% and 18% of sales, respectively. For the quarter ended March 31, 2020, and March 31, 2019, the Company respectively purchased approximately 48% and 36% of its products from one distributor. As of March 31, 2020, four of the Company's customers accounted for 29%, 28%, 14%, and 13% of accounts receivable. As of December 31, 2019, three of the Company's customers accounted for 34%, 21%, and 18% of its accounts receivables.

Commitments

Commitments	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 12 – Commitments The Company was committed under an operating lease for its premises, under which it made monthly payments of $7,500 plus 100% of operating expenses, until the lease expired June 30, 2018. On September 1, 2018, the Company entered a new operating lease with an entity owned by a related party (see Note 10) calling for monthly payments of $8,641 plus 100% of operating expenses, for a term expiring on August 31, 2019. On September 1, 2019, the lease of the Company’s premises was amended such that it expires on August 31, 2020, and the rent thereunder was increased to $8,967 per month. In conjunction with the Asset Purchase Agreement referred to in Note 4, the Company agreed to purchase a minimum of 30,000 units of product per month, subject to an increase of 1% of the agreed purchase on each anniversary of said agreement. The minimum purchase will increase by 1% every anniversary of its effective date. The agreement expires on April 30, 2031.

Subsequent events

Subsequent events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent events	Note 13 – Subsequent Events In December 2019, an outbreak of a novel strain of coronavirus known as COVID-19 originated in Wuhan, China, and has spread to other countries, including the United States. On March 11, 2020, the World Health Organization declared the outbreak to be a pandemic. A number of jurisdictions in the United States, including the State of California, have declared a state of emergency. Further, the governor of the State of California, where the Company’s headquarters, all of its employees and the manufacturer of its Medtainer ® On May 4, 2020, the Company made a note in favor of Customers Bank in the principal amount of $137,690 pursuant to the terms of the Paycheck Protection Program authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act and pursuant to all regulations and guidance promulgated or provided by the Small Business Administration (the “SBA”) and other federal agencies that are now, or may become, applicable to the loan. The loan bears interest at the rate of 1% per annum and has a 2-year term. On June 5, 2020, the CARES Act was amended by the Paycheck Protection Program Flexibility Act of 2020. Under the CARES Act, as so amended, • The loan will be forgiven if its proceeds are used for payroll, mortgage interest, rent, and utilities during the 24-week period beginning on May 4, 2020, although the Company may elect to utilize the 8-week period that was in effect prior to the amendment (such 24- or 8-week period being the “covered period”). The Company has not determined whether it will make this election. The amount of loan forgiveness will be reduced if less than 60% of the funds is expended for payroll over the covered period. • No interest or principal will be required until the date on which the amount of forgiveness determined is remitted to the lender, although interest will continue to accrue over this deferral period. After the deferral period and after taking into account any loan forgiveness applicable to the loan pursuant to the program, as approved by the SBA, any remaining principal and accrued interest will be payable in substantially equal monthly installments over the remaining loan term, in the amount and according to the payment schedule provided by the lender. • Under the amendment to the CARES Act, the Company may apply to the lender to extend the term of the loan to 5 years and expects to do so, but no assurance can be given that the lender will agree to the extension. • The Company may delay the payment of employer payroll taxes until December 31, 2021, with respect to up to 50% of the amounts due and December 31, 2022, with respect to the remaining amounts due up to 50%. On May 21, 2020, the Company issued 20,000,000 shares of Common Stock to an unrelated party in consideration of $200,000. Management evaluated all other subsequent events when these financial statements were issued and determined that none of them requires this disclosure herein.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Accounting principles	Accounting Principles The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the quarter ended March 31, 2020, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on May 28, 2020.
Principles of Consolidation	Principles of Consolidation The unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Certain of the Company’s estimates could be affected by external conditions, including those unique to its industry, and general economic conditions. It is possible that these external conditions could have an effect on the Company’s estimates that could cause actual results to differ from its estimates. The Company re-evaluates all its accounting estimates at least quarterly based on these conditions and record adjustments when necessary. Significant estimates relied upon in preparing these unaudited consolidated financial statements include revenue recognition, accounts receivable reserves, inventory and related reserves, valuations and purchase price allocations related to business combinations, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to intangible assets and goodwill, amortization periods, accrued expenses, share-based compensation, and recoverability of the Company’s net deferred tax assets and any related valuation allowance.
Cash	Cash The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents.
Accounts Receivable	Accounts Receivable Included in “Accounts receivable” on the consolidated balance sheets are amounts primarily related to customers. The Company estimates losses on receivables based on known troubled accounts and historical experience of losses incurred. Receivables are considered impaired and written off when it is probable that all contractual payments due will not be collected in accordance with the terms of the related agreement. Based on experience and the judgment of management, the allowance for doubtful accounts was $0 as of March 31, 2020, and December 31, 2019.
Inventories	Inventories Inventories, which consist of products held for resale, are stated at the lower of cost, determined using the first-in first-out and net realizable value methods. Net realizable value is the estimated selling price, in the ordinary course of business, less estimated costs to complete and dispose of the product. If the Company identifies excess, obsolete or unsalable items, its inventories are written down to their realizable value in the period in which the impairment is first identified. Shipping and handling costs incurred for inventory purchases and product shipments are recorded in cost of sales in the Company’s statements of operations.
Property and Equipment	Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets. For furniture and fixtures the useful life is 5 years, Leasehold Improvements are depreciated over the 2-year lease term. Expenditures for additions and improvements are capitalized; repairs and maintenance are expensed as incurred.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill and intangible assets that have indefinite useful lives are not amortized but are evaluated for impairment annually or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The Company records intangible assets at fair value, estimated using a discounted cash flow approach. The Company amortizes its intangible assets that have finite lives using either the straight-line method or based on estimated future cash flows to approximate the pattern in which the economic benefit of the assets will be utilized. Amortization is recorded over the estimated useful lives ranging from 14 to 20 years. The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that would indicate impairment and trigger a more frequent impairment assessment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, or an adverse action or assessment by a regulator. If the carrying value of an asset exceeds its undiscounted cash flows, the Company will write-down the carrying value of the intangible assets to its fair value in the period identified. The Company generally calculates fair value as the present value of estimated future cash flows to be generated by the asset using a risk-adjusted discount rate. If the estimate of an intangible asset’s remaining useful life is changed, the Company will amortize the remaining carrying value of the intangible asset prospectively over the revised remaining useful life. Consistent with the prior year, the Company conducted its annual impairment test of goodwill during the fourth quarter of the year ended December 31, 2019. The Company operates as a single operating segment with one reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The estimate of fair value requires significant judgment. Any loss resulting from an impairment test would be reflected in operating income in the Company’s consolidated statements of income. The annual impairment testing process is subjective and requires judgment at many points throughout the analysis. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges for these assets not previously recorded. In January 2017, FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment There was no impairment of intangible assets, long-lived assets or goodwill during the quarter ended March 31, 2020.
Convertible Instruments	Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt- and equity-linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.
Revenue Recognition	Revenue Recognition In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 20 l4-09, Revenue from Contracts with Customers (Topic 606) Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations; Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing; Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients; Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. The new revenue standards became effective for the Company on January 1, 2018 and were adopted using the modified retrospective method. The adoption of the new revenue standards did not change the Company’s revenue recognition as the majority of its revenues continue to be recognized when the customer takes control of its product. As the Company did not identify any accounting changes that impacted the amount of reported revenues with respect to its product revenues, no adjustment to retained earnings was required upon adoption. Under the new revenue standards, the Company recognizes revenues when its customer obtains control of promised goods or services, or when they are shipped to that customer, in an amount that reflects the consideration which it expects to receive in exchange for them. The Company recognizes revenues following the five-step model prescribed under ASU No. 2014-09: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) the Company satisfies its performance obligation. Revenues from product sales are recognized when the customer obtains control of the Company’s product, which occurs at a point in time, typically upon shipment or delivery to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have recognized is one year or less or the amount is immaterial. The following table summarizes revenue from contracts with customers for the quarter ended March 31, 2020, and March 31, 2019: Quarter Ended March 31, 2020 2019 Products $ 542,875 $ 582,404 Services 13,254 22,033 Totals $ 556,129 $ 604,437
Share-Based Payments	Share-Based Payments In June 2018, FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, Equity—Equity-Based Payments to Non-Employees.
Fair Value Measurements	Fair Value Measurements The Company has adopted the provisions of ASC Topic 820, Fair Value Measurements and Disclosures, The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of the Company’s short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk. ASC Topic 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC Topic 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC Topic 820 describes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities Level 2 – Quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 – Inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
Advertising	Advertising Advertising and marketing expenses are charged to operations as incurred.
Income Taxes	Income Taxes The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, Income Taxes. ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts. Also, the Company has not experienced losses on accounts receivable and management believes that the Company is not exposed to significant risks with respect to them.
Accounting for Leases	Accounting for Leases In February 2016, FASB issued ASU 2016-02, Leases (Topic 842),

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Summary Of Significant Accounting Policies Tables
Schedule of revenuees	The following table summarizes revenue from contracts with customers for the quarter ended March 31, 2020, and March 31, 2019: Quarter Ended March 31, 2020 2019 Products $ 542,875 $ 582,404 Services 13,254 22,033 Totals $ 556,129 $ 604,437

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Balances at March 31, 2020: Weighted Average Gross Carrying Accumulated Description Estimated Useful Life Value Amortization Net Amount Certain U.S. patents 15 years $ 435,000 $ (51,701 ) $ 383,299 Certain U.S. patents 15 years 435,000 (49,754 ) 385,246 Certain Canadian Patents 20 years 260,000 (23,457 ) 236,543 Certain European Patents 14 years 30,000 (3,783 ) 26,217 Molds 15 years 150,000 (17,829 ) 132,171 Trademark Indefinite life 220,000 — 220,000 Domain name Indefinite life 2,000 — 2,000 Intangible Totals $ 1,532,000 $ (146,524 ) $ 1,385,476 Goodwill $ 1,020,314 $ — $ 1,020,314 Balances at December 31, 2019: Weighted Average Gross Carrying Accumulated Description Estimated Useful Life Value Amortization Net Amount Certain U.S. patents 15 years $ 435,000 $ (44,571 ) $ 390,429 Certain U.S. patents 15 years 435,000 (42,895 ) 392,105 Certain Canadian Patents 20 years 260,000 (20,224 ) 239,776 Certain European Patents 14 years 30,000 (3,262 ) 26,738 Molds 15 years 150,000 (15,370 134,630 Trademark Indefinite life 220,000 — 220,000 Domain name Indefinite life 2,000 — 2,000 Intangible Totals $ 1,532,000 $ (126,322 ) $ 1,405,678 Goodwill $ 1,020,314 $ — $ 1,020,314

Convertible Notes Payable and_2

Convertible Notes Payable and Promissory Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2020
Convertible Notes Payable And Promissory Notes Payable
Schedule of Convertible Notes Payable and Promissory Notes Payable	March 31, 2020 December 31, 2019 Principal Accrued Principal Accrued Convertible Notes Payable July 2014 $75,000 note, convertible into common stock at $5.00 per share, 10% interest, currently in default (a) $ 66,172 $ 25,366 $ 66,172 $ 23,712 July 2014 $15,000 note, convertible into common stock at $5.00 per share, 10% interest, currently in default (a) 15,000 9,750 15,000 9,125 $ 81,172 $ 35,116 $ 81,172 $ 32,837 Notes Payable November 2014 $300,000 note, due February 2019, 10% interest, currently in default (b) $ 298,959 $ 31,919 $ 298,959 $ 34,627 August 2015 $75,000 note, with one-time interest charge of $75,000, currently in default (c) 75,000 75,000 75,000 75,000 373,959 106,919 373,959 109,627 Total $ 455,131 $ 142,035 $ 455,131 $ 142,464

Share Based Compensation (Table

Share Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Share Based Compensation Tables Abstract
Schedule of share based compensation	Shares of Common Stock Vesting Dates Employees Consultants December 31, 2018 — 185,000 January 1, 2019 750,000 — March 31, 2019 — 150,000 June 30, 2019 300,000 — Total vested at March 31, 2020 1,050,000 335,000

Related-Party Transactions (Tab

Related-Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2020
Related-party Transactions
Schedule of related party transactions	Quarter Ended March 31, 2020 2019 Capital lease payments $ — $ 6,000 Building lease payments 21,521 25,921 Purchase of products for resale 26,942 30,221 Total paid to related party $ 48,463 $ 62,142

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Revenues (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Summary Of Significant Accounting Policies - Revenues
Product	$ 542,875	$ 582,404
Service	13,254	22,033
Total	$ 556,129	$ 604,437

Going Concern (Details Narrativ

Going Concern (Details Narrative)	Mar. 31, 2020USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working Capital Deficit	$ 1,656,674

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Net Amount	$ 1,385,476		$ 1,405,678
Certain US Patents 1
Weighted Average Estimated Useful Life	15 years	15 years
Gross Carrying Value	$ 435,000	$ 435,000
Accumulated Amortization	(51,701)	(44,571)
Net Amount	$ 383,299	$ 390,429
Certain US Patents 2
Weighted Average Estimated Useful Life	15 years	15 years
Gross Carrying Value	$ 435,000	$ 435,000
Accumulated Amortization	(49,754)	(42,895)
Net Amount	$ 385,246	$ 392,105
Certain Canadian Patents
Weighted Average Estimated Useful Life	20 years	20 years
Gross Carrying Value	$ 260,000	$ 260,000
Accumulated Amortization	(23,457)	(20,224)
Net Amount	$ 236,543	$ 239,776
Certain European Patents
Weighted Average Estimated Useful Life	14 years	14 years
Gross Carrying Value	$ 30,000	$ 30,000
Accumulated Amortization	(3,783)	(3,262)
Net Amount	$ 26,217	$ 26,738
Molds
Weighted Average Estimated Useful Life	15 years	15 years
Gross Carrying Value	$ 150,000	$ 2,000
Accumulated Amortization	(17,829)
Net Amount	132,171	2,000
Trademark
Gross Carrying Value	220,000	150,000
Accumulated Amortization		(15,370)
Net Amount	220,000	134,630
Domain Name
Gross Carrying Value	2,000	220,000
Accumulated Amortization
Net Amount	2,000	220,000
Intangible Totals
Gross Carrying Value	1,532,000	1,532,000
Accumulated Amortization	(146,524)	(126,322)
Net Amount	1,385,476	1,405,678
Goodwill
Gross Carrying Value	1,020,314	1,020,314
Accumulated Amortization
Net Amount	$ 1,020,314	$ 1,020,314

Convertible Notes Payable and_3

Convertible Notes Payable and Promissory Notes Payable (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
July 2014 $75,000 note, convertible into common stock at $5.00 per share, 10% interest, currently in default (a)
Principal	$ 66,172	$ 66,172
Accrued Interest	25,366	23,712
July 2014 $15,000 note, convertible into common stock at $5.00 per share, 10% interest, currently in default (a)
Principal	15,000	15,000
Accrued Interest	9,750	9,125
November 2014 $300,000 note, due February 2019, 10% interest, currently in default (b)
Principal	298,959	298,959
Accrued Interest	31,919	34,627
August 2015 $75,000 note, with one-time interest charge of $75,000, currently in default (c)
Principal	75,000	75,000
Accrued Interest	$ 75,000	$ 75,000

Share Based Compensation (Detai

Share Based Compensation (Details)	15 Months Ended
	Mar. 31, 2020USD ($)
December 31, 2018
Employees
Consultants	185,000
January 1, 2019
Employees	750,000
Consultants
March 31, 2019
Employees
Consultants	150,000
June 30, 2019
Employees	300,000
Consultants
Total vested at March 31, 2020
Employees	1,050,000
Consultants	$ 335,000

Related-Party Transactions (Det

Related-Party Transactions (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Relatedparty Transactions Details Abstract
Capital lease payments		$ 6,000
Building lease payments	21,521	25,921
Purchase of products for resale	26,942	30,221
Total	$ 48,463	$ 62,142

Concentrations (Details Narrati

Concentrations (Details Narrative)	15 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Purchase Commitment [Member]
Concentration risk percentage	6.00%	18.00%